Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease
Haydeh Payami and colleagues report results of a genome-wide association study for Parkinson's disease. They identify common variants in the HLA region associated with the late-onset sporadic form of the disease and replicate published associations with SNCA , MAPT and GAK . Parkinson's di...
Saved in:
Published in | Nature genetics Vol. 42; no. 9; pp. 781 - 785 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
New York
Nature Publishing Group US
01.09.2010
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Haydeh Payami and colleagues report results of a genome-wide association study for Parkinson's disease. They identify common variants in the
HLA
region associated with the late-onset sporadic form of the disease and replicate published associations with
SNCA
,
MAPT
and
GAK
.
Parkinson's disease is a common disorder that leads to motor and cognitive disability. We performed a genome-wide association study of 2,000 individuals with Parkinson's disease (cases) and 1,986 unaffected controls from the NeuroGenetics Research Consortium (NGRC)
1
,
2
,
3
,
4
,
5
. We confirmed associations with
SNCA
2
,
6
,
7
,
8
and
MAPT
3
,
7
,
8
,
9
, replicated an association with
GAK
9
(using data from the NGRC and a previous study
9
,
P
= 3.2 × 10
−9
) and detected a new association with the
HLA
region (using data from the NGRC only,
P
= 2.9 × 10
−8
), which replicated in two datasets (meta-analysis
P
= 1.9 × 10
−10
). The
HLA
association was uniform across all genetic and environmental risk strata and was strong in sporadic (
P
= 5.5 × 10
−10
) and late-onset (
P
= 2.4 × 10
−8
) disease. The association peak we found was at rs3129882, a noncoding variant in
HLA-DRA
. Two studies have previously suggested that rs3129882 influences expression of
HLA
-
DR
and
HLA-DQ
10
,
11
. The brains of individuals with Parkinson's disease show upregulation of DR antigens and the presence of DR-positive reactive microglia
12
, and nonsteroidal anti-inflammatory drugs reduce Parkinson's disease risk
4
,
13
. The genetic association with
HLA
supports the involvement of the immune system in Parkinson's disease and offers new targets for drug development. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 |
ISSN: | 1061-4036 1546-1718 1546-1718 |
DOI: | 10.1038/ng.642 |